Meijun Zhu Selected Research

Meijun Zhu Research Topics

Disease

11	Neoplasms (Cancer) 01/2019 - 01/2012
5	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 11/2019 - 08/2012
5	Sarcoma (Soft Tissue Sarcoma) 11/2019 - 01/2012
3	Melanoma (Melanoma, Malignant) 09/2013 - 01/2012
2	Pneumonia (Pneumonitis) 01/2022 - 01/2022
2	Inflammation (Inflammations) 01/2022 - 05/2014
2	Obesity 01/2017 - 09/2009
2	Leiomyosarcoma 05/2013 - 10/2012
2	Endometrial Stromal Sarcoma 10/2012 - 01/2012
2	Uveal melanoma 09/2012 - 01/2012
1	Pelvic Inflammatory Disease (Pelvic Inflammatory Diseases) 01/2024
1	Uterine Cervicitis (Cervicitis) 01/2024
1	Endometritis 01/2024
1	Hypoxia (Hypoxemia) 10/2021
1	Carcinogenesis 10/2020
1	Dermatofibrosarcoma 06/2015
1	Hernia (Hernias) 01/2015
1	Muscular Dystrophies (Muscular Dystrophy) 06/2014
1	Frailty 05/2014
1	Leiomyoma (Uterine Fibroids) 05/2013
1	Hypertrophy 01/2011
1	Overnutrition 01/2011
1	Atherosclerosis 01/2010
1	Metabolic Diseases (Metabolic Disease) 09/2009
1	Insulin Resistance 09/2009

Drug/Important Bio-Agent (IBA)

6	Imatinib Mesylate (Gleevec)FDA Link 01/2019 - 07/2012
3	Cyclin D1IBA 01/2019 - 09/2012
3	Proteins (Proteins, Gene)FDA Link 05/2013 - 01/2011
2	Phosphotransferases (Kinase)IBA 11/2019 - 07/2012
2	Small Interfering RNA (siRNA)IBA 01/2017 - 09/2012
2	Oncogene Proteins (Oncogene Protein)IBA 11/2014 - 01/2012
2	Protein Isoforms (Isoforms)IBA 06/2014 - 09/2012
2	Protein Kinase CIBA 09/2012 - 01/2012
2	Codon (Codons)IBA 09/2012 - 01/2012
1	Capsules (Microcapsules)IBA 01/2024
1	N- methyl- N- 2- (methylsulfinyl)ethylpropionic acid amide (NMPA)IBA 01/2024
1	LipidsIBA 01/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022
1	growth arrest specific transcript 5IBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 10/2021
1	LeghemoglobinIBA 10/2021
1	Transcription Factors (Transcription Factor)IBA 10/2020
1	tyrosine receptor (receptor, tyrosine)IBA 11/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2019
1	Insulin ReceptorIBA 01/2017
1	3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA 01/2017
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2017
1	AMP-Activated Protein KinasesIBA 01/2017
1	palbociclibIBA 06/2015
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 06/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2015
1	ponatinibIBA 11/2014
1	DystrophinIBA 06/2014
1	InterleukinsIBA 05/2014
1	Mediator ComplexIBA 05/2013
1	Indicators and Reagents (Reagents)IBA 10/2012
1	CyclinsIBA 10/2012
1	sotrastaurinIBA 09/2012
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 09/2012
1	SurvivinIBA 09/2012
1	Cyclin-Dependent Kinase Inhibitor p27IBA 09/2012
1	(2,4- dihydroxy- 5- isopropylphenyl)- (5- (4- methylpiperazin- 1- ylmethyl)- 1,3- dihydroisoindol- 2- yl)methanoneIBA 08/2012
1	regorafenibIBA 07/2012
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 07/2012
1	Sunitinib (Sutent)FDA Link 07/2012
1	Estrogens (Estrogen)FDA Link 05/2012
1	Progesterone Receptors (Progesterone Receptor)IBA 05/2012
1	14-3-3 Proteins (14-3-3 Protein)IBA 01/2012
1	enzastaurinIBA 01/2012
1	Messenger RNA (mRNA)IBA 01/2011
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2010
1	oxidized low density lipoproteinIBA 01/2010
1	Glucose (Dextrose)FDA LinkGeneric 09/2009
1	Insulin (Novolin)FDA Link 09/2009
1	Hydrocortisone (Cortisol)FDA LinkGeneric 09/2009

Therapy/Procedure

2	Therapeutics 06/2014 - 07/2012
1	Thyroidectomy 01/2015
1	Orthopedic Procedures 01/2015
1	Aftercare (After-Treatment) 08/2012